Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials

Objective: To review the comparative effectiveness of osteoporosis treatments, including the bone anabolic agents, abaloparatide and romosozumab, on reducing the risk of fractures in postmenopausal women, and to characterise the effect of antiosteoporosis drug treatments on the risk of fractures acc...

Full description

Bibliographic Details
Main Authors: Händel, MN, Cardoso, I, von Bülow, C, Rohde, JF, Ussing, A, Nielsen, SM, Christensen, R, Body, J, Brandi, ML, Diez-Perez, A, Hadji, P, Javaid, MK, Lems, WF, Nogues, X, Roux, C, Minisola, S, Kurth, A, Thomas, T, Prieto-Alhambra, D, Ferrari, SL, Langdahl, B, Abrahamsen, B
Format: Journal article
Language:English
Published: British Medical Journal Publishing Group 2023

Similar Items